Highly Potent API (HPAPIs) development and manufacturing

Product description

Dedicated infrastructure for HPAPIThe asset base at our Center of Excellence for HPAPI includes multiple lab-scale, pilot and clinical scale, launch and commercial scale production facilities, thereby providing for seamless development, clinical trial material manufacture and commercialization.

Specialized HPAPI R&D labs and small scale plants are in place support early phase clinical to low volume commercial production of potent compounds (to OEL ≥ 1ng/m3) and ADC payloads. Investment is ongoing to expand HPAPI capacity at all scales and to handle extremely high potent compounds to 1 microgram/m3.

We can also provide integrated services options for HPAPI drug programs inclusive of contained particle engineering and specialized drug product development and manufacturing (sterile fill-finish, liquid-filled hard capsules and soft gels).  
Read more

More products from Lonza Pharma & Biotech

View all our products (52)

Products from other suppliers